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We conducted extensive surveillance for West Nile
virus infection in equines and chickens in Guadeloupe in
2003–2004. We showed a high seroprevalence in equines
in 2003 related to biome, followed by a major decrease in
virus circulation in 2004. No human or equine cases were
reported during the study.
T
he recent introduction of West Nile virus (WNV, fami-
ly Flaviviridae, genus Flavivirus) into the Caribbean
region is a major public health concern, particularly
because transmission of this virus probably occurs year-
round in the neotropics. Since 2002, WNVactivity has been
detected in Guadeloupe (1), Mexico (2,3), the Dominican
Republic (4), and Jamaica (5). The objectives of this study
were to determine the spatial distribution of WNV in
Guadeloupe, establish a surveillance system in humans and
animals to detect clinical cases, and increase our under-
standing of WNV epidemiology in the neotropics.
The Study
The investigation was conducted in the Guadeloupe
archipelago, which includes Guadeloupe (the main island),
Marie Galante, Saint Martin, and Saint Barthelemy.
Surveys of domestic birds (chickens) were performed in
July 2003 and 2004 on 25 to 27 farms selected to cover the
whole island; each farm contained 15–20,000 chickens
from 1 month to 2 years of age. Exhaustive surveys were
also conducted on equines in July 2003 and August 2004
(46 survey locations, 1–68 equines each, mean 10
equines).
Epitope-blocking enzyme-linked immunosorbent
assays (ELISA) were performed by using the WNV-specif-
ic monoclonal antibody 3.1112G and flavivirus-specific
monoclonal antibody 6B6C-1 (Chemicon, Temecula, CA,
USA) as previously described (6,7). The ability of the test
sera to block the binding of the monoclonal antibodies to
WNV antigen was compared to the blocking ability of
horse or chicken serum without antibody to WNV. An inhi-
bition value >30% was considered to indicate the presence
of viral antibodies. Plaque reduction neutralization tests
(PRNTs) were performed as described previously (3) on
serum samples that had antibodies to flaviviruses. PRNTs
were performed with WNV and St. Louis encephalitis
virus (SLEV, family Flaviviridae, genus Flavivirus). A
serum sample was considered to have antibodies to WNV
if it significantly inhibited the binding of monoclonal anti-
body 3.1112G by blocking enzyme-linked immunosorbent
assay (ELISA) and had a 90% plaque reduction (PRNT90)
titer to WNV that was at least 4-fold greater than the cor-
responding SLEV PRNT90 titer. A serum sample was con-
sidered to have antibodies to SLEV if it inhibited the
binding of monoclonal antibody 6B6C-1 and had a
PRNT90 titer to SLEV that was at least 4-fold greater than
the corresponding WNV titer. Aserum sample was consid-
ered to have antibodies to a flavivirus of undetermined ori-
gin if it contained epitope-blocking ELISA or neutralizing
antibodies but did not meet the criteria for a WNV or
SLEV infection.
Out of 487 equines (437 horses, 34 donkeys, 16 ponies)
sampled in July 2003, 94 (19.3%) had antibodies to WNV,
and 10 (2.1%) had antibodies to a flavivirus of undeter-
mined origin (Table 1). In August 2004, of 431 equines
(386 horses, 27 donkeys, 18 ponies), 70 (16.2%) had anti-
bodies to WNV, and 11 (2.6%) had antibodies to a fla-
vivirus of undetermined origin. WNV PRNT90 titers were
between 1:20 and 1:1,280 (mean 1:260).
In 2003, WNV seroprevalence in the 46 equine centers
was highly heterogeneous (0%–100%, chi-square test
p<0.001, Figure 1). This heterogeneity was also found by
county (0%–71%, p<0.001) and by island (p<0.001,
Table 2). 
Figure 2 shows each equine center in relation to the eco-
logic area. Most WNV seropositive equines were located in
evergreen forests characterized by a low altitude (<100 m)
and intensive farming of sugar cane in the vicinity of man-
groves (Rhizophora mangle,  Avicennia germinans,
Laguncularia racemosa, Conocarpus erectus), back man-
groves (marshy forests with Pterocarpus spp.), and
swamps. Within Grande Terre, seropositive equines were
mostly identified in the humid plains of Abymes or near
small mangrove areas. In Marie Galante, nearly all seropos-
itive equines were located near swamps, temporary ponds,
or rivers. Conversely, no seropositive equines were found
in the semideciduous forest (dry leeward coast of Basse
Terre) and very few in the dry regions of Grande Terre.
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December 2002 (1) were retested in July 2003, and all
remained seronegative. Because of changes in the whole
population (e.g., death, exportation), only 328 equines
were tested in both July 2003 and August 2004. Of the 257
seronegative equines identified in 2003, 256 were seroneg-
ative in 2004, and 1 had been infected with an undeter-
mined flavivirus. Thus, no WNV seroconversions were
observed in equines between 2003 and 2004. Conversely,
all the WNV-seropositive equines in 2003 were still posi-
tive in 2004.
In July 2003, of 656 chickens, 11 (1.7%) had antibod-
ies to WNV, and 1 had antibodies to an undetermined fla-
vivirus. Three (0.5%) WNV-seropositive chickens were
found on the main island of Guadeloupe and 8 (14.8%) on
Marie Galante (Figure 1). In July 2004, of 801 chickens, 5
(0.6%) had antibodies to WNV, and 2 had antibodies to an
undetermined flavivirus. All seropositive chickens were on
the main island of Guadeloupe (Figure 1). WNV PRNT90
titers were between 1:20 and 1:1,280 (mean 1:519).
A surveillance system was established in equines,
domestic and wild birds, and humans. Equine surveillance
was performed by veterinarians. Awareness of WNV was
increased in the public, hunters, and horse and poultry
owners with educational leaflets and with the help of vet-
erinarians and natural reserve wardens. In 2003 and 2004,
veterinarians reported 4 horses that exhibited signs of
WNV-like illness (ataxia, weakness of limbs); the horses
were tested at the onset of clinical signs and 15 days later.
All were negative for WNV by epitope-blocking ELISA
and PRNT, and other causes were eventually determined.
Clinical signs were not observed in any equines with anti-
bodies to WNV. Abnormal death and paralysis were report-
ed in domestic chickens in 5 farms. In these farms, serum
specimens from 23 chickens were analyzed for evidence of
WNV infection, and 1 chicken was seropositive.
Human surveillance was performed by the public hos-
pitals of Guadeloupe. In humans, suspected cases were
defined as neurologic symptoms of encephalitis or menin-
goencephalitis or acute neurologic symptoms with fever.
In 2003, the hospital reported 9 suspected cases of clinical
WNV infection in Guadeloupe (Cecile Herrmann-Storck,
pers. comm.). Antibodies to WNV were not detected in the
sera of any of these patients, and another cause was deter-
mined. 
Conclusions
A high seroprevalence (19.3%) for WNV was detected
in equines in 2003. Seropositive equines and chickens
were commonly found near mangroves, which contain
many species of wild birds and mosquitoes. Culex nigri-
palpus and Ochlerotatus taeniorhynchus are common in
Guadeloupe and are particularly abundant in mangrove
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Figure 1. Results of West Nile virus (WNV) serosurveys in chick-
ens and equines in Guadeloupe, 2003–2004. Equine centers are
represented by circles, the sizes of which are proportional to the
numbers of equines. The proportion of WNV-seropositive animals
is represented in red. Chicken farms are represented by triangles
(pointing down for 2003 survey, pointing up for 2004 survey). Red
triangles denote farms where at least 1 seropositive chicken was
identified. All other farms are denoted by yellow triangles. Ab, anti-
body.areas. Culex species are the major amplification vectors of
WNV in the United States (8,9) and may also be vectors of
WNV in Guadeloupe. 
Results of the equine and avian serosurveys suggest
that transmission of WNV decreased dramatically in 2003
and 2004 in comparison to 2002. No equine seroconver-
sion occurred between January 2003 and August 2004, and
seroprevalence in chickens was low in 2003 (1.7%) and
2004 (0.6%). In comparison, 10 of 21 chickens in Goyave
were seropositive for WNV in 2002, although the sample
size was small (1). In the tropics, where temperature is
favorable year-round, changes in rainfall can substantially
affect the size of vector populations (10). Cx. nigripalpus
and Oc. taeniorhynchus need heavy rains or changes in
water level to develop (11). Therefore, the 7-month
drought (half of the usual rainfall) observed between
November 2002 and May 2003 was probably responsible
for a major decrease in the mosquito population. If Cx.
nigripalpus is involved in WNV transmission in
Guadeloupe, a decrease in its population could explain
reduced virus circulation. Alternatively, the number of
nonimmune resident birds may have decreased.
No dead wild bird was reported to the veterinary serv-
ices in Guadeloupe in 2003 or 2004, although dead bird
carcasses are presumably difficult to find in areas with
dense vegetation. No abnormal death rate was noted in
anthropophilic birds either.
Although an efficient passive surveillance system was
implemented in humans and equines, no clinical cases of
WNV infection were observed. This situation is consider-
ably different from that observed in the United States but
mimics the situation in Mexico, where only a few human
and equine cases were observed, despite a seroprevalence
of 29% in equines in 2004 (12). Cross-protection conferred
by other flaviviruses could explain the difference with the
North American situation. In fact, we found some equines
that were considered to have been infected with an
unknown flavivirus. Alternatively, virus mutations could
explain a change in virulence and the absence of clinical
cases. Indeed, recent studies identified attenuated WNV in
Texas (13) and southern Mexico (14). Isolation and char-
acterization of WNV in Guadeloupe would help clarify
these issues.
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Figure 2. Ecologic map of Guadeloupe and West Nile virus (WNV)-
positive equine centers. Basse Terre (southwest) is mainly moun-
tainous (volcanic, highest point 1,467 m) and wet. Grande Terre
(northeast) is flat (mainly <100 m) and dry. Marie Galante is flat
(plateaus <200 m) but has more water than Grande Terre. The
ecologic map was derived from "Carte écologique de la
Guadeloupe," created by Alain Rousteau, University Antilles-
Guyane. Equine centers with WNV-seropositive equines are rep-
resented by red circles (the size of each circle is proportional to the
number of seropositive equines). Centers without WNV-seroposi-
tive equines are represented by white circles (the size of each cir-
cle is proportional to the number of equines tested). The red
asterisk shows a site that contained 3 seropositive equines. All
were race horses that travel frequently and thus may have been
infected elsewhere.References
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Landscape
Mary Oliver
Isn't it plain the sheets of moss, except that
they have no tongues, could lecture
all day if they wanted about
spiritual patience? Isn't it clear
the black oaks along the path are standing
as though they were the most fragile of flowers?
Every morning I walk like this around
the pond, thinking: if the doors of my heart
ever close, I am as good as dead.
Every morning, so far, I'm alive. And now
the crows break off from the rest of the darkness
and burst up into the sky—as though
all night they had thought of what they would like
their lives to be, and imagined
their strong, thick wings.
From Dream Work, copyright 1986 by Mary Oliver. 
Used by permission of Grove/Atlantic, Inc., and the author.